ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing
There has been a rise in deals and investment to grow US manufacturing operations, due to impending tariffs on the sector.
Drug Manufacturers
Solid tumours: CAR-T therapies’ Waterloo
Genentech to onshore US manufacturing amid rising drug pricing tensions
Can pharma tariffs “Make America Manufacture Again”?
Revamping US pharma manufacturing: Trump’s executive order faces industry doubts
Roche plans $700m manufacturing plant in the US
Thermo Fisher counters tariffs with $2bn investment into US manufacturing
3 reasons why biotechs preparing for launch need a compliant content foundation
